
Keywords: AGEs; advanced glycation end-products; ALR1; aldehyde reductase; ALR2; aldose reductase; ARI; aldose reductase inhibitor; BEI; binding efficiency index; DHN; 1,4-dihydroxynonene; GSH; glutathione; HNE; 4-hydroxynonenal; LE; ligand efficiency; LELP; ligand